8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Brain & Nervous System704 citations

Radiats Biol Radioecol 57(1):71-76, 2017

Bioeffects Seen

Authors not listed · 2017

Share:

Disrupted cell death pathways drive major brain diseases, highlighting why protecting neurons from EMF-induced cellular stress matters.

Plain English Summary

Summary written for general audiences

This comprehensive review examined how different types of programmed cell death contribute to neurological diseases like Alzheimer's, Parkinson's, and brain cancers. Researchers found that abnormal cell death pathways are a common feature across neurodegenerative diseases, while insufficient cell death contributes to brain tumor development. The findings highlight potential therapeutic targets for treating brain diseases by either promoting or blocking specific cell death mechanisms.

Why This Matters

While this study doesn't directly examine EMF exposure, it provides crucial context for understanding how electromagnetic fields might contribute to neurological disease. The research demonstrates that disrupted cell death pathways are central to conditions like Alzheimer's and Parkinson's disease. What's particularly relevant is that EMF exposure has been shown in other studies to trigger oxidative stress and inflammatory responses in brain tissue - the same cellular stresses this review identifies as triggers for abnormal cell death. The reality is that our brains are constantly exposed to unprecedented levels of electromagnetic radiation from phones, WiFi, and other wireless devices. If these exposures are indeed causing the type of cellular stress that leads to aberrant cell death pathways, we could be looking at a significant contributing factor to the rising rates of neurodegenerative diseases. The science demonstrates that protecting brain cells from unnecessary stress should be a priority, and that includes minimizing EMF exposure where practical.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2017). Radiats Biol Radioecol 57(1):71-76, 2017.
Show BibTeX
@article{radiats_biol_radioecol_57171_76_2017_ce3903,
  author = {Unknown},
  title = {Radiats Biol Radioecol 57(1):71-76, 2017},
  year = {2017},
  doi = {10.1038/s41418-021-00814-y},
  
}
DOI: 10.1038/s41418-021-00814-yPubMed: 34099897

Quick Questions About This Study

The study identified five main types: apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy-associated cell death. These programmed death pathways become abnormally activated in neurodegenerative diseases, leading to unwanted loss of brain cells and function.
Brain cancers show the opposite problem - insufficient cell death. When programmed cell death pathways are inactivated, abnormal cells survive when they should die, contributing to tumor development and making cancers more resistant to treatment.
Various forms of cellular stress from intracellular or extracellular sources can activate these pathways, along with inflammatory processes. The study emphasizes that protecting brain cells from unnecessary stress is crucial for preventing disease.
Yes, researchers are developing drugs that can either inhibit or induce programmed cell death depending on the disease. Some agents targeting key cell death proteins have already progressed to clinical trials for brain diseases.
The review found aberrant cell death pathways in amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, Huntington's disease, and various brain cancers. This suggests cell death disruption is a common mechanism across neurological conditions.